Skip to main content
. 2018 Nov 8;12:3825–3845. doi: 10.2147/DDDT.S183527

Figure 6.

Figure 6

(A) Forest plot of the adverse events risks between the macrolides group and the placebo group. (B) Subgroup analysis of the adverse events risks by the type of macrolides. (C) Subgroup analysis of the adverse events risks by the age group.